MedTrace Logo

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

NCT04604002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2024-02-28

No results posted yet for this study

Summary

Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations

Conditions

  • Retinal Vascular
  • Normal Eyes

Interventions

DEVICE

OCT Angiography

OCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes.

DEVICE

Color Fundus Photography

Non-contact white light photography

DEVICE

Optical Coherence Tomography

A non-contact test that uses light waves to take cross-sectional pictures of the retina

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • Dennis Marcus, MD · Southeast Retina Center

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2022-01-04
Completion
2022-01-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04604002 on ClinicalTrials.gov